entity

AMYLOID_PLAQUES

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about AMYLOID_PLAQUES: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

7Connections
0Hypotheses
1Analyses
4Outgoing
3Incoming
0Experiments
1Debates

No AI portrait yet

Outgoing (4)

TargetRelationTypeStr
CSF_p-tau217drives_elevation_viafluid_biomarker0.00
GSK3Bactivatesenzyme0.00
CDK5activatesenzyme0.00
axonal_transportimpairsbiological_process0.00

Incoming (3)

SourceRelationTypeStr
donanemabclearstherapeutic_agent0.00
AL002Cinhibitsdrug0.64
TREM2responds_toprotein0.64

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (1)

Scientific analyses that reference this entity

Can CSF p-tau217 normalization serve as a reliable surrogate endpoint for determ

neurodegeneration | 2026-04-26 | 7 hypotheses Top: 0.560

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

Can CSF p-tau217 normalization serve as a reliable surrogate endpoint for determ

active · Rounds: 4 · Score: 1.00 · 2026-04-26

Related Research

Hypotheses and analyses mentioning AMYLOID_PLAQUES in their description or question text

No additional research found